Elevance Health Welcomes Steve Collis as New Board Director
PorAinvest
lunes, 28 de julio de 2025, 9:10 pm ET1 min de lectura
COR--
Collis brings a distinguished record of leadership, transformation, and operational excellence. He currently serves as Executive Chairman of the Board of Cencora (formerly AmerisourceBergen), a role he assumed in 2024 after a long tenure as President and CEO. During his 13-year tenure as CEO, Collis led Cencora through significant strategic transformation, expanding its global reach and deepening its capabilities across the pharmaceutical and healthcare supply chain [1].
Ramey Peru, Chair of the Elevance Health Board of Directors, stated, "Steve brings deep experience in healthcare operations and long-term value creation, aligning well with our strategic objectives. His insights will support our continued focus on delivering high-quality care, driving innovation, and creating enduring value for the people and communities we serve" [1].
Elevance Health, a lifetime, trusted health partner, supports consumers, families, and communities across the entire healthcare journey. The company serves over 109 million consumers through a diverse portfolio of industry-leading medical, pharmacy, behavioral, clinical, home health, and complex care solutions [1].
References:
[1] https://www.elevancehealth.com/newsroom/elevance-health-board-welcomes-steve-collis-as-new-director
[2] https://www.morningstar.com/news/business-wire/20250728510661/elevance-health-board-welcomes-steve-collis-as-new-director-reflecting-ongoing-commitment-to-governance-excellence
[3] https://www.businesswire.com/news/home/20250728510661/en/Elevance-Health-Board-Welcomes-Steve-Collis-as-New-Director-Reflecting-Ongoing-Commitment-to-Governance-Excellence
ELV--
Elevance Health's board of directors welcomes Steve Collis, a global healthcare executive, as a new director, effective August 1. He will serve on the Audit and Finance Committees, enhancing the board's industry expertise and financial oversight capabilities. His addition is part of the board's ongoing commitment to governance excellence and strategy refresh.
Elevance Health (NYSE: ELV) has announced the addition of Steve Collis to its board of directors, effective August 1, 2025. Collis, a highly regarded global healthcare executive, will serve on the Audit and Finance Committees, enhancing the board's industry expertise and financial oversight capabilities. His appointment reflects the company's ongoing commitment to governance excellence and strategic refresh [1].Collis brings a distinguished record of leadership, transformation, and operational excellence. He currently serves as Executive Chairman of the Board of Cencora (formerly AmerisourceBergen), a role he assumed in 2024 after a long tenure as President and CEO. During his 13-year tenure as CEO, Collis led Cencora through significant strategic transformation, expanding its global reach and deepening its capabilities across the pharmaceutical and healthcare supply chain [1].
Ramey Peru, Chair of the Elevance Health Board of Directors, stated, "Steve brings deep experience in healthcare operations and long-term value creation, aligning well with our strategic objectives. His insights will support our continued focus on delivering high-quality care, driving innovation, and creating enduring value for the people and communities we serve" [1].
Elevance Health, a lifetime, trusted health partner, supports consumers, families, and communities across the entire healthcare journey. The company serves over 109 million consumers through a diverse portfolio of industry-leading medical, pharmacy, behavioral, clinical, home health, and complex care solutions [1].
References:
[1] https://www.elevancehealth.com/newsroom/elevance-health-board-welcomes-steve-collis-as-new-director
[2] https://www.morningstar.com/news/business-wire/20250728510661/elevance-health-board-welcomes-steve-collis-as-new-director-reflecting-ongoing-commitment-to-governance-excellence
[3] https://www.businesswire.com/news/home/20250728510661/en/Elevance-Health-Board-Welcomes-Steve-Collis-as-New-Director-Reflecting-Ongoing-Commitment-to-Governance-Excellence
Divulgación editorial y transparencia de la IA: Ainvest News utiliza tecnología avanzada de Modelos de Lenguaje Largo (LLM) para sintetizar y analizar datos de mercado en tiempo real. Para garantizar los más altos estándares de integridad, cada artículo se somete a un riguroso proceso de verificación con participación humana.
Mientras la IA asiste en el procesamiento de datos y la redacción inicial, un miembro editorial profesional de Ainvest revisa, verifica y aprueba de forma independiente todo el contenido para garantizar su precisión y cumplimiento con los estándares editoriales de Ainvest Fintech Inc. Esta supervisión humana está diseñada para mitigar las alucinaciones de la IA y garantizar el contexto financiero.
Advertencia sobre inversiones: Este contenido se proporciona únicamente con fines informativos y no constituye asesoramiento profesional de inversión, legal o financiero. Los mercados conllevan riesgos inherentes. Se recomienda a los usuarios que realicen una investigación independiente o consulten a un asesor financiero certificado antes de tomar cualquier decisión. Ainvest Fintech Inc. se exime de toda responsabilidad por las acciones tomadas con base en esta información. ¿Encontró un error? Reportar un problema

Comentarios
Aún no hay comentarios